Alkermes
ALKS · NASDAQ
Bulios Fair Price
$25.38
41.5% downside
Trenutna cena
$43.39
Po podatkih Bulios Fair Price je delnica ALKS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Alkermes plc is a global biotechnology company focused on the development and manufacturing of innovative medicines for the treatment of neuropsychiatric and oncological diseases. Founded in 1987 and headquartered in Dublin, Ireland, Alkermes specializes in developing drugs for the treatment of mental health disorders such as schizophrenia, depression, and addiction, as well as cancer therapies. The company is known for its technology in the production of long-acting injectable medications, aiming to provide patients with effective and accessible treatment options.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Blair Jackson
Employees
2,050
Headquarters
Dublin
Prihajajoči dogodki
Earnings
Upcoming earnings report